Beta Bionics, Inc. · NASDAQ:BBNX
Feider Stephen sold 744 Beta Bionics, Inc. shares (Form 4)
Traded Nov 9, 2026 · Filed Nov 12, 2026
On Nov 9, 2026, Feider Stephen (Chief Financial Officer) sold 744 Beta Bionics, Inc. shares at US$17.00 for US$12,649 under a trading plan, leaving 159,378 shares. Filed Nov 12, 2026 (Form 4).
- Sold
- 744 shares
- Price
- US$17.00
- Value
- US$12,649
- Holding after
- 159,378 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | Common Stock | Option exercise | 744 | US$5.10 | 160,122 | Direct |
| Nov 9, 2026 | Common Stock | Sale | 744 | US$17.00 | 159,378 | Direct |
Source
Download original · View original at SEC
Related
- Beta Bionics, Inc.
- Feider Stephen
- Beta Bionics, Inc. shareholders
- Form 4 · Feider Stephen · Nov 13, 2026
- Form 4 · Feider Stephen · Nov 9, 2026
- Form 4 · Feider Stephen · Sep 3, 2026
- Form 4/A · Feider Stephen · Jul 2, 2026
- Form 4 · Feider Stephen · Jun 30, 2026
- Form 4 · Hopman Mark · Nov 18, 2026
- Schedule 13G/A · Divisadero Street Capital Management, LP · Nov 16, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Nov 16, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Nov 9, 2026
- Form 4 · Hopman Mark · Nov 4, 2026